Greater Cannabis Company (GCAN) Change in Accured Expenses (2016 - 2026)

Greater Cannabis Company's (GCAN) quarterly Change in Accured Expenses came in at $30000.0 in Q1 2026, little changed year-on-year from $30000.0 in Q1 2025, and up 200.0% quarter-over-quarter from $10000.0 in Q4 2025.

Greater Cannabis Company (GCAN) Change in Accured Expenses (2016 - 2026) Analysis & Trends

Greater Cannabis Company's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $30000.0 for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses changed 0.0% year-over-year to $30000.0 in Q1 2026; TTM through Mar 2026 was $90000.0, a 91.06% increase from a year earlier, with the FY2025 full-year figure at $90000.0, up 295.34% from the prior year.
  • Change in Accured Expenses improved to $30000.0 in Q1 2026 per GCAN's latest filing, from $10000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $56400.0 in Q2 2023 and bottomed at -$56962.0 in Q4 2023.
  • The 5-year median for Change in Accured Expenses is $10000.0 (2023), against an average of $10599.6.
  • Biggest YoY gain for Change in Accured Expenses was 1445.9% in 2023; the steepest drop was 1209.72% in 2023.
  • Year by year, Change in Accured Expenses stood at $5133.0 in 2022, then sank by 1209.72% to -$56962.0 in 2023, then jumped by 122.41% to $12765.0 in 2024, then slipped by 21.66% to $10000.0 in 2025, then soared by 200.0% to $30000.0 in 2026.
  • Per Business Quant, the three latest GCAN Change in Accured Expenses figures stand at $30000.0 (Q1 2026), $10000.0 (Q4 2025), and $30000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -144.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -12.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Greater Cannabis Company 292,929.85 292,929.85 - 30,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 30,000.00
Mar 31, 2026 30,000.00
Dec 31, 2025 10,000.00
Dec 31, 2025 10,000.00
Sep 30, 2025 30,000.00
Sep 30, 2025 30,000.00
Jun 30, 2025 20,000.00
Jun 30, 2025 20,000.00
Mar 31, 2025 30,000.00
Mar 31, 2025 30,000.00
Dec 31, 2024 12,765.00
Dec 31, 2024 12,765.00
Sep 30, 2024 20,000.00
Sep 30, 2024 20,000.00
Jun 30, 2024 -15,660.00
Jun 30, 2024 -15,660.00
Mar 31, 2024 5,660.00
Mar 31, 2024 5,660.00
Dec 31, 2023 -56,962.00
Dec 31, 2023 -56,962.00